{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:30:40Z","timestamp":1789738240357,"version":"4.0.1"},"reference-count":36,"publisher":"China Science Publishing & Media Ltd.","issue":"11","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672635"],"award-info":[{"award-number":["81672635"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673544"],"award-info":[{"award-number":["81673544"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973710"],"award-info":[{"award-number":["81973710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974469"],"award-info":[{"award-number":["81974469"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hunan Provincial Key Program for Research and 636 Development","award":["2018SK21310"],"award-info":[{"award-number":["2018SK21310"]}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1093\/abbs\/gmaa116","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T19:12:33Z","timestamp":1598469153000},"page":"1257-1264","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["ARG1 functions as a tumor suppressor in breast cancer"],"prefix":"10.3724","volume":"52","author":[{"given":"Zhengnan","family":"Ming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizheng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaimei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y i","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"Siegel RL","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin, 2019, 69: 7-34.","journal-title":"CA Cancer J Clin"},{"key":"null","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"Harbeck N","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K. Breast cancer. Nat Rev Dis Primers, 2019, 5:","journal-title":"Nat Rev Dis Primers"},{"key":"null","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJMcibr1909386","volume":"381","author":"Hayes DF","year":"2019","unstructured":"Hayes DF. HER2 and breast cancer\u2014a phenomenal success story. N Engl J Med, 2019, 381: 1284-1286.","journal-title":"N Engl J Med"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003284","volume":"9","author":"Nickels S","year":"2013","unstructured":"Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U. Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet, 2013, 9:","journal-title":"PLoS Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/hmg\/ddw066","volume":"25","author":"Thirthagiri E","year":"2016","unstructured":"Thirthagiri E, Klarmann K, Shukla A, Southon E, Biswas K, Martin B, North S. BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation. Hum Mol Genet, 2016, 25: 1934-1945.","journal-title":"Hum Mol Genet"},{"key":"null","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4048\/jbc.2018.21.e41","volume":"21","author":"Temian D","year":"2018","unstructured":"Temian D, Pop L, Irimie A, Berindan-Neagoe I. The epigenetics of triple-negative and basal-like breast cancer: current knowledge. J Breast Cancer, 2018, 21: 233-243.","journal-title":"J Breast Cancer"},{"key":"null","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4048\/jbc.2012.15.1.34","volume":"15","author":"Hwang S","year":"2012","unstructured":"Hwang S, Bae J, Lee H, Kim H. Circulating tumor cells detected by RT-PCR for CK-20 before surgery indicate worse prognostic impact in triple-negative and HER2 subtype breast cancer. J Breast Cancer, 2012, 15: 34-42.","journal-title":"J Breast Cancer"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14549-9","volume":"7","author":"Hachim I","year":"2017","unstructured":"Hachim I, Villatoro M, Canaff L, Hachim M, Boudreault J, Haiub H, Ali S. Transforming growth factor-beta regulation of Ephrin type-A receptor 4 signaling in breast cancer cellular migration. Sci Rep, 2017, 7:","journal-title":"Sci Rep"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06868-4","volume":"20","author":"Bloom M","year":"2020","unstructured":"Bloom M, Jarrett A, Triplett T, Syed A, Davis T, Yankeelov T, Sorace A. Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+ breast cancer. BMC Cancer, 2020, 20:","journal-title":"BMC Cancer"},{"key":"null","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3360001","volume":"336","author":"Wu G","year":"1998","unstructured":"Wu G, Morris SM. Arginine metabolism: nitric oxide and beyond. Biochem J, 1998, 336: 1-17.","journal-title":"Biochem J"},{"key":"null","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.113.005924","volume":"128","author":"Michel T","year":"2013","unstructured":"Michel T. R is for arginine: metabolism of arginine takes off again in new directions. Circulation, 2013, 128: 1400-1404.","journal-title":"Circulation"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00331-y","volume":"8","author":"Zaytouni T","year":"2017","unstructured":"Zaytouni T, Tsai PY, Hitchcock DS, DuBois CD, Freinkman E, Lin L, Morales-Oyarvide V. Critical role for arginase 2 in obesity-associated pancreatic cancer. Nat Commun, 2017, 8:","journal-title":"Nat Commun"},{"key":"null","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","volume":"64","author":"Rodriguez PC","year":"2004","unstructured":"Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, Piazuelo MB, Delgado A. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res, 2004, 64: 5839-5849.","journal-title":"Cancer Res"},{"key":"null","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1476-5381.2009.00291.x","volume":"158","author":"Munder M","year":"2009","unstructured":"Munder M. Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol, 2009, 158: 638-651.","journal-title":"Br J Pharmacol"},{"key":"null","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2217\/imt-2016-0118","volume":"9","author":"Timosenko E","year":"2017","unstructured":"Timosenko E, Hadjinicolaou AV, Cerundolo V. Modulation of cancer-specific immune responses by amino acid degrading enzymes. Immunotherapy, 2017, 9: 83-97.","journal-title":"Immunotherapy"},{"key":"null","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/humu.23545","volume":"39","author":"Diez-Fernandez C","year":"2018","unstructured":"Diez-Fernandez C, Rufenacht V, Gemperle C, Fingerhut R, Haberle J. Mutations and common variants in the human arginase 1 (ARG1) gene: impact on patients, diagnostics, and protein structure considerations. Hum Mutat, 2018, 39: 1029-1050.","journal-title":"Hum Mutat"},{"key":"null","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.drudis.2018.01.046","volume":"23","author":"Pham TN","year":"2018","unstructured":"Pham TN, Liagre B, Girard-Thernier C, Demougeot C. Research of novel anticancer agents targeting arginase inhibition. Drug Discov Today, 2018, 23: 871-878.","journal-title":"Drug Discov Today"},{"key":"null","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cmet.2016.10.019","volume":"24","author":"Kishton RJ","year":"2016","unstructured":"Kishton RJ, Sukumar M, Restifo NP. Arginine arms T cells to thrive and survive. Cell Metab, 2016, 24: 647-648.","journal-title":"Cell Metab"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-0190504-5","volume":"7","author":"Miret J","year":"2019","unstructured":"Miret J, Kirschmeier P, Koyama S, Zhu M, Li Y, Naito Y, Wu M. Suppression of myeloid cell arginase activity leads to therapeutic response in a NSCLC mouse model by activating anti-tumor immunity. J Immunother Cancer, 2019, 7:","journal-title":"J Immunother Cancer"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8696923","volume":"2018","author":"Avtandilyan N","year":"2018","unstructured":"Avtandilyan N, Javrushyan H, Petrosyan G, Trchounian A. The involvement of arginase and nitric oxide synthase in breast cancer development: arginase and NO synthase as therapeutic targets in cancer. Biomed Res Int, 2018, 2018:","journal-title":"Biomed Res Int"},{"key":"null","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.clinbiochem.2014.03.019","volume":"47","author":"Chrzanowska A","year":"2014","unstructured":"Chrzanowska A, Grabo\u0144 W, Mielczarek-Puta M, Bara\u0144czyk-Ku\u017ama A. Significance of arginase determination in body fluids of patients with hepatocellular carcinoma and liver cirrhosis before and after surgical treatment. Clin Biochem, 2014, 47: 1056-1059.","journal-title":"Clin Biochem"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041215","volume":"19","author":"Shosha E","year":"2018","unstructured":"Shosha E, Xu Z, Narayanan S, Lemtalsi T, Fouda A, Rojas M, Xing J. Mechanisms of diabetes-induced endothelial cell senescence: role of arginase 1. Int J Mol Sci, 2018, 19:","journal-title":"Int J Mol Sci"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.3390\/nu11071463","volume":"11","author":"Bollenbach A","year":"2019","unstructured":"Bollenbach A, Huneau J, Mariotti F, Tsikas D. Asymmetric and symmetric protein arginine dimethylation: concept and postprandial effects of high-fat protein meals in healthy overweight men. Nutrients, 2019, 11:","journal-title":"Nutrients"},{"key":"null","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2014-09-600643","volume":"125","author":"Mussai F","year":"2015","unstructured":"Mussai F, Egan S, Higginbotham-Jones J, Perry T, Beggs A, Odintsova E, Loke J. Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target. Blood, 2015, 125: 2386-2396.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1152\/physrev.00037.2016","volume":"98","author":"Caldwell RW","year":"2018","unstructured":"Caldwell RW, Rodriguez PC, Toque HA, Narayanan SP, Caldwell RB. Arginase: a multifaceted enzyme important in health and disease. Physiol Rev, 2018, 98: 641-665.","journal-title":"Physiol Rev"},{"key":"null","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jacc.2017.05.019","volume":"70","author":"Finkelman BS","year":"2017","unstructured":"Finkelman BS, Putt M, Wang T, Wang L, Narayan H, Domchek S, DeMichele A. Arginine-nitric oxide metabolites and cardiac dysfunction in patients with breast cancer. J Am Coll Cardiol, 2017, 70: 152-162.","journal-title":"J Am Coll Cardiol"},{"key":"null","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","volume":"222","author":"Rodriguez PC","year":"2008","unstructured":"Rodriguez PC, Ochoa AC. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev, 2008, 222: 180-191.","journal-title":"Immunol Rev"},{"key":"null","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ni.3421","volume":"17","author":"Monticelli LA","year":"2016","unstructured":"Monticelli LA, Buck MD, Flamar AL, Saenz SA, Tait Wojno ED, Yudanin NA, Osborne LC. Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat Immunol, 2016, 17: 656-665.","journal-title":"Nat Immunol"},{"key":"null","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/jn\/137.6.1681S","volume":"137","author":"Popovic PJ","year":"2007","unstructured":"Popovic PJ, Zeh HJ, Ochoa JB. Arginine and immunity. J Nutr, 2007, 137: 1681-1686.","journal-title":"J Nutr"},{"key":"null","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.4049\/jimmunol.1003460","volume":"187","author":"Sharda DR","year":"2011","unstructured":"Sharda DR, Yu S, Ray M, Squadrito ML, De Palma M, Wynn TA, Morris SM. Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase. J Immunol, 2011, 187: 2181-2192.","journal-title":"J Immunol"},{"key":"null","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tranon.2019.10.001","volume":"13","author":"Zhong S","year":"2020","unstructured":"Zhong S, Jeong JH, Chen Z, Luo JL. Targeting tumor microenvironment by small-molecule inhibitors. Transl Oncol, 2020, 13: 57-69.","journal-title":"Transl Oncol"},{"key":"null","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature11017","volume":"486","author":"Stephens PJ","year":"2012","unstructured":"Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S. The landscape of cancer genes and mutational processes in breast cancer. Nature, 2012, 486: 400-404.","journal-title":"Nature"},{"key":"null","first-page":"1962","volume":"17","author":"Kanaizumi H","year":"2019","unstructured":"Kanaizumi H, Higashi C, Tanaka Y, Hamada M, Shinzaki W, Azumi T, Hashimoto Y. PI3K\/Akt\/mTOR signalling pathway activation in patients with ER-positive, metachronous, contralateral breast cancer treated with hormone therapy. Oncol Lett, 2019, 17: 1962-1968.","journal-title":"Oncol Lett"},{"key":"null","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-018-4697-y","volume":"169","author":"Costa RLB","year":"2018","unstructured":"Costa RLB, Han HS, Gradishar WJ. Targeting the PI3K\/AKT\/mTOR pathway in triple-negative breast cancer: a review. Breast Cancer Res Treat, 2018, 169: 397-406.","journal-title":"Breast Cancer Res Treat"},{"key":"null","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1200\/JCO.2014.59.0018","volume":"34","author":"LoRusso PM","year":"2016","unstructured":"LoRusso PM. Inhibition of the PI3K\/AKT\/mTOR pathway in solid tumors. J Clin Oncol, 2016, 34: 3803-3815.","journal-title":"J Clin Oncol"},{"key":"null","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ccell.2015.07.003","volume":"28","author":"Ooms LM","year":"2015","unstructured":"Ooms LM, Binge LC, Davies EM, Rahman P, Conway JR, Gurung R, Ferguson DT. The inositol polyphosphate 5-phosphatase PIPP regulates AKT1-dependent breast cancer growth and metastasis. Cancer Cell, 2015, 28: 155-169.","journal-title":"Cancer Cell"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/7DD8A37D5A204FF3A4D6808C5368AE51","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmaa116","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/abbs\/article-pdf\/52\/11\/1257\/34860816\/gmaa116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/7DD8A37D5A204FF3A4D6808C5368AE51","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T03:55:57Z","timestamp":1668052557000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmaa116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,10,30]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmaa116","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}